Tag: Cell Bank
ATCC Awarded Two Contracts from Gennova Biopharmaceuticals for the Continued Development of Cell Banks...
ATCC, the world’s premier biological materials management, and standards organization announced that it has been awarded two contracts from Gennova Biopharmaceuticals Limited, on behalf of the U.S. Food and Drug Administration (FDA), to continue its work with the biotechnology...
Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges
Recent scientific advancements have made stem cell therapy an emerging and promising area of research. The establishment of stem cell banks around the globe has been growing rapidly, aimed at preserving the characteristics of the cells, preventing contamination, and...
Cryopreservation and Biobanking Could Save the World’s Rarest Species from Extinction
Scientists at the Chester Zoo in the UK have teamed up with some of the UK’s leading animal reproduction experts and founded Nature’s SAFE, which stands for Saving Animals From Extinction. Nature’s SAFE is one of Europe’s largest living...
A Ubiquitination Inhibitor Hakin-1 Potentially Has Efficacy In Colorectal Cancer
Hakai is a 491 amino acid E3 ubiquitin-protein ligase that forms a dimer if zinc is available. This allows Src tyrosine kinase dependant interaction with the transmembrane adhesion protein E-cadherin. This interaction results in ubiquitination and degradation of E-cadherin,...
351 Lymphoblastoid Cell Lines Added To NIA Aging Cell Repository At Coriell Institute
Hundreds of biological samples donated from individuals aged
90 years or older have been added to the National Institute on Aging’s (NIA) Aging
Cell Repository, housed at the Coriell Institute for Medical Research. The
samples, a total of 351 lymphoblastoid cell lines,...
Grünenthal And Mesoblast Partner To Develop Allogeneic Cell Therapy For Chronic Low Back Pain
Grünenthal, a global leader in pain management, and
Mesoblast Limited, a world leader in allogeneic cellular medicines for
inflammatory diseases, have entered into a strategic partnership to develop and
commercialise MPC-06-ID, a Phase III allogeneic cell therapy candidate for the
treatment of chronic...
Chan Zuckerberg Initiative Awards $68 Million To Further Develop The Human Cell Atlas
The Chan Zuckerberg Initiative (CZI) has announced $68
million in funding to support the Human Cell Atlas and its selection of 38
collaborative science teams to launch CZI's Seed Networks for Human Cell Atlas
projects. These collaborative groups bring together scientists, computational
biologists,...
Teneobio and Selexis Partner To Develop Manufacturing Grade Oncology-Targeting Research Cell Banks
Selexis SA and Teneobio, Inc. have announced that they have
entered into a second services agreement to expand Teneobio’s oncology pipeline
of Human Heavy-Chain Antibodies (UniAbs™), a new class of multi-specific
biologics. Under the agreement, Teneobio will utilize Selexis’ proprietary
SUREtechnology Platform™ to...
